Most pacemaker pocket infections, without lead involvement, responded completely to antibiotics given locally at high concentrations in a case-control study.
A small trial reported a 60% response rate to neoadjuvant immunochemotherapy in oral squamous cell carcinoma. The study was published as a preprint and has not yet been peer reviewed.
An epidemiologist and advocates say state and local officials in West Virginia, home to one of the worst HIV outbreaks in recent years, have taken measures that render syringe exchange less accessible.
Patients with stage IIA and IIB esophageal squamous cell carcinoma with lymphovascular invasion but negative lymph nodes do not benefit. The study was published as a preprint and has not yet been peer reviewed.